Contraceptive Sponges Market Overview Analysis:
Contraceptive Sponges Market was worth US$ xx million in 2019, and it is estimated to reach a valuation of US$ xx million by the end of 2025, expanding at a healthy CAGR.
The contraceptive sponge is a type of contraception that prevents sperm from entering the uterus. They are usually soft, disk-shaped, and made of polyurethane foam. Contraceptive sponges contain spermicides that block or kill sperm. This device is interested in the vagina before sexual intercourse. These are generally 2 inches in diameter and have a ring for easy removal. The method or medication used for contraception interferes with the ordinary course of sperm-egg fertilization to prevent pregnancy.
Mayor Laboratories, Inc., a US-based company that manufactures and sells health and reproductive products, has hired Blossom Organics, Inc. to distribute the company's intimately and naturally purely managed products exclusively to all retail, wholesale and government channels. Signed from the United States, Europe, and Canada.
As the importance of family planning increases, it is expected to lead the growth of the global contraceptive sponge market during the forecast period. Compared to birth control pills, the safety associated with birth control sponges is also one of the undoubted reasons for the growth of the market for these sponges. The contraceptive sponge can be used for a long time without removing it, regardless of the number of sexual intercourse, due to which sales of contraceptive sponges are also supposed to increase. However, these contraceptive sponges cannot prevent sexually transmitted diseases, which can be a market limitation. Contraceptive sponges are not as effective as condoms to avoid pregnancy, restricting the rapid extension of this industry.
The market for contraceptive sponges is presumed to grow significantly during the forecast period. The increase in family planning programs and the adoption of voluntary family planning measures are expected to stimulate the market for contraceptive sponges. Contraceptives can cause health-related complications, but they are safe to use. They also showed essential results in preventing pregnancy. Another factor that is predicted to accelerate the growth of the market for contraceptive sponges is that it is easy to use and does not interfere with sex. The use of social media marketing to inform people about contraceptive sponges is also driving growth.
A spermicide impregnated with a contraceptive sponge kills the sperm and prevents it from reaching the uterus. Especially in women who have not been previously administered, the high effect of sponges is likely to lead to the growth of the global contraceptive sponges market. These sponges are readily available, are over-the-counter (OTC) products and are available in pharmacy stores. E-commerce or online pharmacies are expected to make this distribution channel more accessible and more comfortable to access, resulting in the fastest-growing end-user segment.
The main challenge in the market is that contraceptive sponges cannot prevent sexually transmitted diseases such as HIV and AIDS, and many competitive products such as condoms and pills are more effective in preventing pregnancy.
The global contraceptive sponge market is classified by type and distribution channels.
By type, the global contraceptive sponges market has been bifurcated as ordinary and ultrathin.
By distribution channel, the global contraceptive sponges market is segmented into pharmacies, online stores, and others. Of these, the pharmacies, comprising both retail and hospital, accounted for the most substantial portion of the worldwide market in the review period. However, in the coming years, online stores are predicted to witness the highest demand because of the convenience and door-step delivery they offer. The increasing penetration of smartphones and the internet will act as a catalyst for the expansion of the online segment in this industry.
Geographically, the global contraceptive sponge market can be divided into the Asia Pacific region excluding Japan, North America, Latin America, Western Europe, Eastern Europe, Japan and the Middle East and Africa.
North America is the largest market for contraceptive sponges and is expected to remain dominant during the forecast period, as the product awareness and concentration in the region are increasing. Europe is the second-largest market for contraceptive sponges. Women in this area increasingly use contraception to prevent pregnancy due to carrier-related approaches.
In Asia-Pacific, with the exception of Japan and Japan, significant growth in the market for contraceptive sponges is anticipated, with greater awareness of the side effects of contraceptives and the use of social media marketing. The increase in government programs on family planning is foreseen to lead the growth of contraceptive sponges business in this region of Asia Pacific.
Pirri Pharma Canada, Inc., a Canadian-based company that manufactures and sells medical and reproductive products, is part of PharmaEng International Inc. It signed an exclusive supply agreement, a wholly-owned subsidiary with Keata Pharma Inc. Commercial manufacturing and labeling of Protected products.
Main companies operating in the global contraceptive sponges market are Teva Pharmaceutical Industries Limited, Pirri Pharma, Tree of Life Pharma, Merck & Co., Inc., Women's Health Company, Allergan plc, Pfizer, Inc., Bayer AG, Innotech International, Cooper Companies, Inc., Mayer Laboratories, Ansell LTD., Sager Pharma Kft, and Innothera
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Contraceptive Sponges Market, By Type
6.1.3 Market Size Estimations & Forecasts (2019-2024)
6.1.4 Y-o-Y Growth Rate Analysis
6.1.5 Market Attractiveness Index
6.2 Contraceptive Sponges Market, By Distribution Channel
6.2.2 Online Stores
6.2.3 Market Size Estimations & Forecasts (2019-2024)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2018 - 2024)
7.2.1 By Country
7.2.2 By Type
7.2.3 By Distribution Channel
7.3.1 By Country
18.104.22.168 Rest of Europe
7.3.2 By Type
7.3.3 By Distribution Channel
7.4 Asia Pacific
7.4.1 By Country
22.214.171.124 South Korea
126.96.36.199 South East Asia
188.8.131.52 Australia & NZ
184.108.40.206 Rest of Asia-Pacific
7.4.2 By Type
7.4.3 By Distribution Channel
7.5 Latin America
7.5.1 By Country
220.127.116.11 Rest of Latin America
7.5.2 By Type
7.5.3 By Distribution Channel
7.6 Middle East and Africa
7.6.1 By Country
18.104.22.168 Middle East
7.6.2 By Type
7.6.3 By Distribution Channel
8. Key Player Analysis
8.1 Teva Pharmaceutical Industries Limited
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Merck & Co., Inc
8.3 Mayer Laboratories
8.4 Allergan plc
8.5 Pfizer, Inc
8.6 Pirri Pharma
8.7 Tree of Life Pharma
8.8 Innotech International
8.9 Sager Pharma Kft
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures